Recent Drug News and Approvals

Features

Emerging Treatments in Schizophrenia

Emerging Treatments in Schizophrenia

A recent article by Brown and Roffman reviews emerging targets and adjunctive agents under investigation, which may target the negative symptoms and cognitive impairment associated with schizophrenia.

The Theranos Story Reminds the Medical World of its Greatest Burden: Proof

The Theranos Story Reminds the Medical World of its Greatest Burden: Proof

The last few months have witnessed the unraveling of the remarkable life sciences company Theranos, culminating in the latest news that federal regulators may ban founder Elizabeth Holmes from the blood-testing industry for at least 2 years.

Achieving Glycemic Control in Older Patients: A Delicate Balancing Act

Achieving Glycemic Control in Older Patients: A Delicate Balancing Act

Diabetes mellitus - especially type 2 diabetes (T2DM) - is becoming increasingly common among US residents aged 65 and older. In 2010, 10.9 million (26.9%) of this population had diabetes, and the number is expected to continue rising to 26.7 million by 2050.